Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of RTS,S/AS01 Malaria Vaccine in HIV-Infected Children
NCT01148459Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2010
- Primary completion
- May 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of RTS,S in malaria (2 arms), sponsored by GSK. Primary endpoint: Number of Subjects With Serious Adverse Events. Started Jul 2010; status: completed.
02
Drugs
RTS,S
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01148459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01148459.